|
|
Volumn 35, Issue 12, 2012, Pages
|
|
The TOSCA.IT trial: A study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLUCOSE;
METFORMIN;
PIOGLITAZONE;
SULFONYLUREA;
ADD ON THERAPY;
ARTICLE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL EVALUATION;
CLINICAL TRIAL (TOPIC);
COMBINATION CHEMOTHERAPY;
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
EVIDENCE BASED MEDICINE;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HUMAN;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
QUALITY OF LIFE;
RISK REDUCTION;
STUDY DESIGN;
AGED;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MIDDLE AGED;
QUALITY OF LIFE;
SULFONYLUREA COMPOUNDS;
THIAZOLIDINEDIONES;
TREATMENT OUTCOME;
|
|
EID: 84869840288
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc12-0954 Document Type: Article |
|
Times cited : (22)
|
|
References (5)
|
